Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5376
BondBloxx Bloomberg Two Year Target Duration US Treasury ETF
XTWO
$270M
| $550K | ﹤0.01% |
11,233
-25,559
| -69% | -$1.25M |
2024 Q3
7 quarters
|
|
5377
iShares iBonds 2031 Term High Yield and Income ETF
IBHK
$92M
| $548K | ﹤0.01% |
21,260
-1,061
| -5% | -$27.2K |
2025 Q3
3 quarters
|
|
5378
iShares 1-10 Year U.S. Aggregate Bond ETF
AGGM
$130M
| $548K | ﹤0.01% |
5,275
-46
| -0.9% | -$4.77K |
2013 Q2
52 quarters
|
|
5379
Xilio Therapeutics
XLO
$59.4M
| $546K | ﹤0.01% |
56,954
-539
| -0.9% | -$4.5K |
2021 Q4
18 quarters
|
|
5380
ROBO Global Artificial Intelligence ETF
THNQ
$484M
| $545K | ﹤0.01% |
5,979
-1
| -0% | -$78 |
2020 Q4
22 quarters
|
|
5381
GMO Ultra-Short Income ETF
GMOC
$35.1M
| $545K | ﹤0.01% |
+10,890
| New | +$546K |
2026 Q2
0 quarters
|
|
5382
Neumora Therapeutics
NMRA
$80.2M
| $543K | ﹤0.01% |
319,421
-184,398
| -37% | -$351K |
2023 Q3
11 quarters
|
|
5383
Stellus Capital Investment Corp
SCM
$206M
| $542K | ﹤0.01% |
64,355
-83,400
| -56% | -$765K |
2013 Q2
52 quarters
|
|
5384
The Elmet Group
ELMT
$594M
| $540K | ﹤0.01% |
+27,372
| New | +$470K |
2026 Q2
0 quarters
|
|
5385
TAT Technologies
TATT
$419M
| $540K | ﹤0.01% |
11,199
-31,721
| -74% | -$1.27M |
2013 Q4
50 quarters
|
|
5386
Biomea Fusion
BMEA
$60.6M
| $540K | ﹤0.01% |
367,021
+20,279
| +6% | +$30.3K |
2021 Q2
20 quarters
|
|
5387
ARK 21Shares Bitcoin ETF
ARKB
$3.14B
| $539K | ﹤0.01% |
27,701
-1,831
| -6% | -$43.6K |
2024 Q1
9 quarters
|
|
5388
PayPay
PAYP
$9.92B
| $538K | ﹤0.01% |
37,530
-120,232
| -76% | -$2.21M |
2026 Q1
1 quarter
|
|
5389
EagleRock Land
EROK
$482M
| $537K | ﹤0.01% |
+25,257
| New | +$546K |
2026 Q2
0 quarters
|
|
5390
Lake Shore Bancorp
LSBK
$142M
| $537K | ﹤0.01% |
30,133
+228
| +0.8% | +$3.64K |
2014 Q1
49 quarters
|
|
5391
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.15B
| $534K | ﹤0.01% |
17,919
+16,476
| +1,142% | +$540K |
2023 Q3
11 quarters
|
|
5392
Franklin Master Intermediate Income Trust
PIM
$147M
| $534K | ﹤0.01% |
165,353
-6,245
| -4% | -$20K |
2013 Q2
52 quarters
|
|
5393
ProShares UltraShort Bloomberg Crude Oil
SCO
$892M
| $534K | ﹤0.01% |
15,240
+8,558
| +128% | +$247K |
2013 Q3
51 quarters
|
|
5394
Starfighters Space Inc
FJET
$69.3M
| $533K | ﹤0.01% |
100,243
+28,046
| +39% | +$168K |
2025 Q4
2 quarters
|
|
5395
Core Molding Technologies
CMT
$207M
| $533K | ﹤0.01% |
22,578
-838
| -4% | -$20.6K |
2019 Q2
28 quarters
|
|
5396
Alpha Tau Medical
DRTS
$1.22B
| $533K | ﹤0.01% |
42,354
+17,883
| +73% | +$162K |
2022 Q1
17 quarters
|
|
5397
US Vegan Climate ETF
VEGN
$182M
| $532K | ﹤0.01% |
6,472
| – | – |
2019 Q4
26 quarters
|
|
5398
Schwab 1-5 Year Corporate Bond ETF
SCHJ
$900M
| $531K | ﹤0.01% |
21,529
+20,036
| +1,342% | +$494K |
2020 Q3
23 quarters
|
|
5399
Powerus Corporation Common Stock
PUSA
$299M
| $527K | ﹤0.01% |
132,029
+128,029
| +3,201% | +$537K |
2025 Q4
2 quarters
|
|
5400
Evernorth Holdings Inc. Class A Ordinary Shares
XRPN
$358M
| $527K | ﹤0.01% |
50,540
-21
| -0% | -$218 |
2025 Q2
4 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.